Previous Article | Next Article 
Molecular and Cellular Biology, July 2000, p. 4979-4989, Vol. 20, No. 14
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Activation of MEK Kinase 1 by the c-Abl Protein
Tyrosine Kinase in Response to DNA Damage
Surender
Kharbanda,1,*
Pramod
Pandey,1
Teruo
Yamauchi,1
Shailender
Kumar,1
Masao
Kaneki,1
Vijay
Kumar,1
Ajit
Bharti,1
Zhi-Min
Yuan,1
Louis
Ghanem,2
Ajay
Rana,2
Ralph
Weichselbaum,3
Gary
Johnson,4 and
Donald
Kufe1
Dana Farber Cancer Institute, Harvard Medical School,
Boston, Massachusetts 021151; Diabetes
Research Laboratory, Department of Molecular Biology, Massachusetts
General Hospital, Harvard Medical School, Boston, Massachusetts
021142; Department of Radiation and
Cellular Oncology, University of Chicago, Chicago, Illinois
606373; and Division of Basic
Sciences, National Jewish Center for Immunology and Respiratory
Medicine, Denver, Colorado 802624
Received 23 December 1999/Returned for modification 2 February
2000/Accepted 12 April 2000
 |
ABSTRACT |
The c-Abl protein tyrosine kinase is activated by certain
DNA-damaging agents and regulates induction of the stress-activated c-Jun N-terminal protein kinase (SAPK). Here we show that nuclear c-Abl
associates with MEK kinase 1 (MEKK-1), an upstream effector of the
SEK1
SAPK pathway, in the response of cells to genotoxic stress. The
results demonstrate that the nuclear c-Abl binds to MEKK-1 and that
c-Abl phosphorylates MEKK-1 in vitro and in vivo. Transient-transfection studies with wild-type and kinase-inactive c-Abl
demonstrate c-Abl kinase-dependent activation of MEKK-1. Moreover,
c-Abl activates MEKK-1 in vitro and in response to DNA damage. The
results also demonstrate that c-Abl induces MEKK-1-mediated phosphorylation and activation of SEK1-SAPK in coupled kinase assays.
These findings indicate that c-Abl functions upstream of
MEKK-1-dependent activation of SAPK in the response to genotoxic stress.
 |
INTRODUCTION |
c-Abl is a nonreceptor tyrosine
kinase that is localized to the nucleus and cytoplasm. c-Abl is
ubiquitously expressed as two 145-kDa isoforms (1a and 1b) as a result
of alternative splicing of the first two exons (3). Targeted
disruption of the c-abl gene in mice is associated with normal fetal
development (59, 68). However, the animals are born runted,
with head and eye abnormalities, and succumb as neonates with defective
lymphopoiesis (59, 68). c-Abl is activated by ionizing
radiation (IR) and certain other DNA-damaging agents (27, 30,
41). The DNA-dependent protein kinase (DNA-PK) and the ataxia
telangiectasia mutated (ATM) gene product, effectors in the DNA damage
response, contribute to the induction of c-Abl activity (2, 28,
60). Overexpression of c-Abl induces arrest in the G1
phase of the cell cycle by a mechanism dependent on p53 (18, 44,
58). Other work has shown that IR induces binding of c-Abl to p53
and G1 growth arrest by a p53-dependent, p21-independent
mechanism (78). In addition, Rad51, a protein that promotes
homologous DNA strand exchange and functions in recombinational DNA
repair, is regulated by c-Abl-mediated phosphorylation (77).
Activation of c-Abl by IR and certain other DNA-damaging agents also
contributes to the induction of stress-activated protein kinases (SAPK;
also known as c-Jun N-terminal protein kinase) (29, 30, 48).
In concert with c-Abl functioning as an upstream effector of SAPK,
other studies have shown that transient overexpression of active forms
of Abl stimulates SAPK activity (50, 53, 57).
SAPK is a member of the mitogen-activated protein kinase (MAPK) family
that also includes extracellular signal-regulated kinase (ERK) and the
p38 MAPK (6, 9, 10, 19, 23, 34, 35, 43, 69, 73). In addition
to DNA damage, SAPK is activated by cellular stress signals induced by
the inflammatory cytokines, tumor necrosis factor (TNF), and
interleukin-1 (10, 35). The activity of SAPK is regulated by
SAPK-ERK kinase 1 (SEK1) (57), also known as MKK4
(11), or MKK7 (67), which in turn is a substrate
of MEK kinase 1 (MEKK-1) (76). The catalytic domain of
MEKK-1 is homologous to the kinase domain of the STE 11 serine-threonine protein kinase involved in the control of mating in
Saccharomyces cerevisiae (14). MEKK-1 is parallel
to Raf-1 in the MAPK signaling cascade (38) and to MTK1 in
the p38 MAPK pathway (63, 64). However, while a number of
putative kinases, including MEKK-1, MEKK-2, MEKK-3, MEKK-4,
TAK-1, MLK-3, SPRK, Tp12, and ASK1, have been reported to activate
SEK1, MKK7, MKK3, or MKK6 (4, 20, 22, 39, 51, 56, 64, 76),
the upstream activators of these MAPKKKs are largely unknown. The Rho
GTPases, PAKs, and STE20-like kinases regulate SAPK activation by
interacting with MEKK-1 (6-8, 33, 42, 49, 51, 65, 81). In
addition, protein kinase C
(PKC
) phosphorylates and activates
MEKK-1 in phorbol ester-induced SAPK activation and differentiation of
myeloid leukemia cells (24). By contrast, it is not known if
MEKK-1 is involved in DNA damage-induced activation of SAPK.
The present studies demonstrate that c-Abl is an upstream effector of
MEKK-1 in DNA damage-induced activation of SAPK. c-Abl associates with
MEKK-1 in response to IR and other genotoxic agents. The results also
demonstrate c-Abl-dependent activation of MEKK-1. These findings
indicate that c-Abl functions upstream of MEKK-1 and that MEKK-1
controls activation of SAPK in the response to DNA damage.
 |
MATERIALS AND METHODS |
Cell culture.
Human U-937 myeloid leukemia cells (American
Type Culture Collection Rockville, Md.) (suspension cells) were grown
in RPMI 1640 medium supplemented with 10% heat-inactivated fetal
bovine serum (HI-FBS), 100 U of penicillin per ml, 100 µg of
streptomycin per ml, and 2 mM L-glutamine. Human embryonic
kidney HEK293T (adherent) cells were grown in Dulbecco modified Eagle
medium with 10% HI-FBS and antibiotics. Irradiation was performed at
room temperature using a Gammacell 1000 (Atomic Energy of Canada,
Ottawa, Ontario, Canada) under aerobic conditions with a
137Cs source emitting at a fixed dose rate of 13.3 Gy/min
as determined by dosimetery. Cells were also treated with 20 ng of
human recombinant TNF per ml (6.60 × 106 U/mg of
protein; BASF, Inc., Worcester, Mass.) or 50 µM cisplatinum (CDDP;
Sigma Chemical Co., St. Louis, Mo.).
Subcellular fractionation.
Subcellular fractionation was
performed as described previously (5). Cells were washed
twice with cold phosphate-buffered saline (PBS) and resuspended in 1 ml
hypotonic lysis buffer (1 mM EGTA, 1 mM EDTA, 10 mM
-glycerophosphate, 0.5 mM sodium orthovanadate, 2 mM
MgCl2, 10 mM KCl, 1 mM dithiothreitol [DTT], 40 µg of
phenylmethylsulfonyl fluoride per ml, 10 µg of leupeptin per ml, and
10 µg of aprotinin per ml; pH 7.2). After swelling on ice for 30 min,
the cells were disrupted by Dounce homogenization (20 strokes). The
homogenate was layered onto 1 ml of 1 M sucrose in lysis buffer and
centrifuged at 1,600 × g for 15 min to pellet the
nuclei. The supernatant above the sucrose cushion was collected and
centrifuged at 150,000 × g for 30 min at 4°C to
collect the soluble or cytoplasmic fraction. The nuclear pellet was
resuspended in lysis buffer containing 1% NP-40 and 0.5%
deoxycholate. The nuclear lysates were sonicated briefly on ice and
centrifuged to remove the undissolved debris. The supernatant was used
as a nuclear fraction.
Immunoprecipitation and immunoblot analysis.
Cells (2 × 107 to 3 × 107) were washed twice with
ice-cold PBS and lysed in 1 ml of lysis buffer (50 mM Tris, pH 7.4; 150 mM NaCl; 0.5% NP-40; 0.5% Brij-96; 1 mM sodium vanadate; 1 mM
phenylmethylsulfonyl fluoride; 1 mM DTT; 10 µg of leupeptin and
aprotinin per ml). Soluble proteins (ca. 200 µg) were incubated with
anti-c-Abl (2 µg, K12; Santa Cruz Biotechnology, San Diego, Calif.)
or anti-MEKK-1 (1 µg) (37) for 1 h and precipitated
by using protein A-Sepharose for an additional 30 min. The immune
complexes were washed three times with lysis buffer, separated by
electrophoresis in 7.5 or 10% sodium dodecyl sulfate
(SDS)-polyacrylamide gels, and then transferred to nitrocellulose
filters. After blocking with 5% milk in PBST (PBS in 0.05% Tween 20),
the filters were incubated with anti-c-Abl (1:1,000 dilution,
monoclonal antibody Ab-3; Oncogene Science) or anti-MEKK-1 (1:500
dilution) for 1 h and analyzed by chemiluminescence (ECL Detection
System; Amersham).
Fusion protein binding assays.
Glutatione
S-transferase (GST)-MEKK-1 was purified by affinity
chromatography using glutathione-Sepharose beads. Lysates (200 to 250 µg) were incubated with 5 µg of immobilized GST or GST-MEKK-1 for
2 h at 4°C. The resulting protein complexes were washed three times with lysis buffer containing 0.1% NP-40 and boiled for 5 min in
SDS sample buffer. The complexes were then separated by SDS-7.5%
polyacrylamide gel electrophoresis (PAGE) and subjected to immunoblot
analysis with anti-c-Abl (1:1,000 dilution). Lysates from irradiated
U-937 cells were incubated with 5 µg of GST or GST-c-Abl SH3
(52) for 2 h at 4°C. The SH3 domain of c-Abl consists of 50 to 60 amino acids near the N terminus (nucleotides 209 to 408)
that mediate protein-protein interactions by binding to
proline-containing sites (52).
Coupled kinase assays.
Cells (2 × 107 to
3 × 107) were washed with PBS and lysed in 1 ml of
lysis buffer. The cleared supernatants (600 µl) were incubated with
preimmune rabbit serum (PIRS) or anti-c-Abl (2 µg, K12; Santa Cruz).
The precipitated proteins were recovered on protein A-Sepharose beads
and washed three times with lysis buffer, twice with 1 M LiCl, and
twice with kinase buffer A (50 mM HEPES, 10 mM MgCl2, 2 mM
DTT, 0.1 mM NaV). The immunoprecipitated proteins were incubated with
purified soluble GST-SEK1 (0.3 to 0.5 µg) in the presence of
Mg2+ and ATP for 15 min at 30°C. The reaction was
terminated by sedimentation of the beads. The supernatant was incubated
with recombinant SAPK purified from bacteria for 15 min at 30°C
followed by addition of GST-Jun and then incubation for an additional
15 min before termination with SDS.
Transient transfections and immunoprecipitations.
293T cells
were seeded 24 h before transfection. Each plate was transfected
in the presence of 1 ml of calcium phosphate coprecipitate containing 5 µg of DNA. After 12 h of incubation at 37°C, the medium was
replaced and the cells were incubated for another 24 h. Cell
lysates were prepared as described above and 200 to 250 µg of soluble
proteins was incubated with PIRS, anti-c-Abl, anti-hemagglutinin (anti-HA), anti-GST, or anti-MEKK-1 and then analyzed by immunoblotting with the indicated antibodies. The protein complexes were washed with
lysis buffer and then incubated in kinase buffer containing [
-32P]ATP for 15 min at 30°C. Reactions were
terminated by the addition of SDS-PAGE sample buffer and boiling.
Phosphorylated proteins were resolved by SDS-PAGE and autoradiography.
c-Jun kinase assays.
293T cells were transfected with
pEBG-SAPK (57), pEBG-SEK1 (57), HA-MEKK-1
(75), HA-MEKK-1(K-R) (75), and c-Abl
(58) or c-Abl(K-R) (58). After 12 h of
incubation at 37°C, the medium was replaced and the cells were
incubated for another 24 h. Cell lysates were prepared as
described above, and 200 to 250 µg of soluble proteins was incubated
with 5 µg of immobilized GST for 30 min at 4°C. The protein
complexes were washed with lysis buffer and then incubated in kinase
buffer containing [
-32P]ATP for 15 min at 30°C.
Reactions were terminated by the addition of SDS-PAGE sample buffer and
boiling. Phosphorylated proteins were resolved by SDS-PAGE and analyzed
by autoradiography.
In vitro binding of c-Abl and MEKK-1.
The 85-kDa truncated
form of MEKK-1 (70, 71) was labeled with
[35S]methionine using pSupercatch-MEKK-1 (17,
21) in an in vitro translation system (TNT T7 Coupled
Reticulocyte Lysate System; Promega). 35S-labeled MEKK-1
was incubated with glutathione-Sepharose beads bound to GST-c-Abl,
GST-c-Abl(K-R), or GST in buffer A (50 mM HEPES, pH 7.4; 10 mM
MnCl2; 10 mM MgCl2; 100 µM ATP) for 30 min at
30°C. Adsorbates were assayed by SDS-PAGE and autoradiography.
In vitro phosphorylation of MEKK-1.
GST-MEKK-1 (5 µg,
Escherichia coli derived, 14-176; Upstate Biotechnology) or
GST was incubated in buffer A with GST-c-Abl and
[
-32P]ATP for 30 min at 30°C. H6-MEKK-1
(amino acids 565 to 1100; Santa Cruz Biotechnology) was separately
incubated with GST-c-Abl and [
-32P]ATP for 30 min at
30°C. Phosphorylation of the reaction products was assessed by
SDS-PAGE and autoradiography. Kinase reactions were also performed in
the presence of cold ATP, and the phosphorylated products were
separated by SDS-PAGE, transferred to nitrocellulose, and analyzed by
immunoblotting with anti-P-Tyr.
MEKK-1 activity assays in vitro.
A cDNA for the
carboxy-terminal 80-kDa MEKK-1 was amplified by PCR using the rat
full-length MEKK-1 (75) as a template and cloned into the
yeast p426GAG expression vector which contains the GST domain under
control of the yeast GAL1 promoter (63). GST-MEKK-1 (yeast
derived; yMEKK-1) (24) or GST bound to glutathione beads was
pretreated with calf intestinal alkaline phosphatase (1 µl, 27.8 U/µl; GIBCO-BRL) for 1 h at 37°C. The beads were washed three
times with lysis buffer containing 1% NP-40, twice with 0.5 M
LiCl-100 mM Tris-HCl (pH 7.6), and once with kinase buffer B (20 mM
Tris-HCl, pH 7.6; 20 mM MgCl2; 2 mM CaCl2). To
purify c-Abl, Sf9 cells were infected with baculoviruses expressing
GST-c-Abl or GST-c-Abl(K-R), and the lysates were purified by
glutathione beads. GST-c-Abl or GST-c-Abl(K-R) fusion proteins were
eluted from the beads and used in the kinase reactions. The beads
containing GST-MEKK-1 were then incubated in buffer B in the presence
of 1.0 µl of recombinant purified c-Abl or recombinant purified
c-Abl(K-R) for 30 min at 30°C. After the kinase reaction, the beads
were washed three times with lysis buffer containing 1% NP-40, twice with 0.5 M LiCl-100 mM Tris-HCl (pH 7.6) containing 1% NP-40 and 0.5% deoxycholic acid, and once with 50 mM HEPES (pH 7.4), 10 mM
MgCl2. Kinase reactions were performed in 50 mM HEPES (pH
7.4), 10 mM MgCl2, 20 µM ATP, [
-32P]ATP,
and 5 µg of GST-SEK1(K-R) (57) for 5 min at 30°C. The reaction was terminated by the addition of SDS sample buffer and boiling. The reaction products were analyzed by SDS-PAGE and autoradiography.
 |
RESULTS |
Interactions of c-Abl with MEKK-1.
To determine whether c-Abl
associates with MEKK-1, we transiently overexpressed HA-MEKK-1 with
c-Abl in 293T cells and analyzed anti-c-Abl immunoprecipitates by
immunoblotting with anti-HA. Reactivity of anti-HA with a >200-kDa
protein supported the coprecipitation of MEKK-1 and c-Abl (Fig.
1A). In the reciprocal experiment,
anti-HA immunoprecipitates were subjected to immunoblot analysis with anti-c-Abl. The results confirmed the identification of a complex containing MEKK-1 and c-Abl (Fig. 1B, upper panel). Analysis of anti-HA
immunoprecipitates by immunoblotting with anti-HA demonstrated overexpression of HA-MEKK-1 (Fig. 1B, bottom panel). Lysates from transfected 293T cells were also subjected to immunoprecipitation with
anti-c-Abl. Analysis of protein precipitates by immunoblotting with
anti-c-Abl demonstrated equal levels of c-Abl under both experimental
conditions (Fig. 1B, middle panel). 293T cells were also
transiently cotransfected with c-Abl and pEBG-SEK1, pEBG-SAPK, or
HA-MEKK-1. GST-protein adsorbates or anti-HA immunoprecipitates were
analyzed by immunoblotting with anti-c-Abl. The results demonstrate that, in contrast to MEKK-1, there is no detectable association of
c-Abl with SEK1 or SAPK (Fig. 1C). Analysis of anti-GST and anti-HA
protein precipitates by immunoblotting with anti-GST and anti-HA,
respectively, demonstrated equal expression of GST-SEK1, GST-SAPK, and
HA-MEKK-1 (data not shown). Taken together, these findings indicate
that c-Abl specifically associates with MEKK-1.

View larger version (43K):
[in this window]
[in a new window]
|
FIG. 1.
Association of c-Abl with MEKK-1. (A) 293T cells were
transiently transfected with c-Abl (+) and vector ( ) (lane 1) or
c-Abl (+) and HA-MEKK-1 (+) (lane 2). Cell lysates were subjected to
immunoprecipitation with anti-c-Abl, and the precipitates were analyzed
by immunoblotting with anti-HA antibody. (B) 293T cells were
transiently transfected with vector ( ), c-Abl (+), or c-Abl and
HA-MEKK-1. Cell lysates were subjected to immunoprecipitation with
anti-HA, and the precipitates were analyzed by immunoblotting with
anti-c-Abl antibody (upper panel). Anti-HA immunoprecipitates were also
analyzed by immunoblotting with anti-HA (middle panel). As a control,
lysates were subjected to immunoprecipitation with anti-c-Abl, and the
precipitates were analyzed by immunoblotting with anti-c-Abl (bottom
panel). (C) 293T cells were transiently transfected with c-Abl and
pEBG-SEK1, pEBG-SAPK, or HA-MEKK-1. Cell lysates were subjected to
protein precipitation with GST or immunoprecipitation with anti-HA as
indicated. The protein precipitates were analyzed by immunoblotting
with anti-c-Abl.
|
|
DNA damage induces the interaction of nuclear c-Abl and
MEKK-1.
To assess potential interactions between c-Abl and MEKK-1
in response to DNA damage, U-937 cells were exposed to 20-Gy IR and
harvested after 30 min, and total cell lysates were subjected to
immunoprecipitation with PIRS or anti-c-Abl antibody. The
immunoprecipitates were analyzed by immunoblotting with anti-MEKK-1.
The full-length MEKK-1 cDNA encodes a 185- to 196-kDa protein
(75), but in certain cell types MEKK-1 is expressed as an
~80- to 85-kDa protein containing the kinase domain (70).
There was little if any constitutive binding of c-Abl and the 80- to
85-kDa form of MEKK-1, whereas exposure to IR resulted in induction of
this interaction (Fig. 2A). In the
reciprocal experiment, anti-MEKK-1 immunoprecipitates were analyzed
with anti-c-Abl. The results confirmed an IR-dependent association of
c-Abl and MEKK-1 (Fig. 2B). U-937 cells were also exposed to 5- or
10-Gy IR and harvested after various intervals (0 or 30 min or 1 or
3 h). Lower exposures to IR resulted in induction of the
interaction between c-Abl and MEKK-1 at 1 to 3 h (data not shown).
To determine the specificity of c-Abl-MEKK-1 interactions in response
to IR, 293T cells were transiently transfected with c-Abl and
pEBG-SAPK, pEBG-SEK1, HA-SPRK (51) or HA-MEKK-1. Following transfection, cells were exposed to IR, and lysates were subjected to
immunoprecipitation with anti-GST or anti-HA. The immunoprecipitates were analyzed by immunoblotting with anti-c-Abl. The results
demonstrate that, in contrast to MEKK-1, there is no detectable
association of c-Abl with SPRK, SAPK, or SEK1 (Fig. 2C and data not
shown). Moreover, immunoblot analysis of total cell lysates with
anti-GST and anti-HA demonstrated consistent equal expression of the
transfected genes (data not shown). IR induces single and double DNA
strand breaks, and cisplatinum (CDDP) forms DNA intrastrand cross-links (62). Treatment of U-937 cells with CDDP was also associated with increased binding of c-Abl and MEKK-1 (Fig. 2D). SAPK is activated
by TNF (35), but by a c-Abl-independent mechanism (30). In this context, unlike IR and alkylating agents, TNF failed to induce the binding of c-Abl and MEKK-1 (Fig. 2D).

View larger version (58K):
[in this window]
[in a new window]
|
FIG. 2.
Genotoxic agents induce association of c-Abl and MEKK-1.
(A) U-937 cells were treated with 20-Gy IR and lysed at 15 min. Equal
amounts of proteins were subjected to immunoprecipitation with
anti-c-Abl or PIRS. The precipitated proteins were analyzed by
immunoblotting with anti-MEKK-1 (upper panel) or anti-c-Abl (lower
panel). IgH, the heavy chain of immunoglobulin G. (B) U-937 cells were
treated with IR and harvested at the indicated times. Lysates were
immunoprecipitated with anti-MEKK-1. The immunoprecipitates were
analyzed by immunoblotting with anti-c-Abl (upper panel). As a control,
anti-c-Abl immunoprecipitates were also analyzed by immunoblotting with
anti-c-Abl (bottom panel). (C) 293T cells were cotransfected with c-Abl
and pEBG-SEK1 or pEBG-SAPK. At 36 h after transfection, cells were
exposed to 20-Gy IR and harvested after 1 h. Cell lysates were
subjected to protein precipitation by GST, and the precipitates were
analyzed by immunoblotting with anti-c-Abl. Analysis of anti-GST and
anti-HA immunoprecipitates by immunoblotting with anti-GST and anti-HA
demonstrated equal expression of GST-SEK1, GST-SAPK, and HA-MEKK-1.
(D) U-937 cells were treated with IR and harvested at 15 min. Cells
were also treated with 50 µM CDDP for 1 h or 20 ng of TNF per ml
for 10 min. Lysates were immunoprecipitated with anti-c-Abl, and the
precipitates were analyzed by immunoblotting with anti-MEKK-1.
|
|
To define the subcellular localization of the interaction between c-Abl
and MEKK-1, we subjected nuclear and cytoplasmic lysates from
control and irradiated cells to immunoprecipitation with anti-c-Abl.
Immunoblot analysis of the immunoprecipitates from control cells
demonstrated little if any reactivity with MEKK-1 in the nuclear
fraction. A low constitutive interaction between c-Abl and MEKK-1 was
detected in the cytoplasmic fraction (Fig. 3C). By contrast, the association of
c-Abl and MEKK-1 was significantly increased in the nuclear, but not
cytoplasmic, lysates from irradiated cells (Fig. 3A and C). This
interaction between c-Abl and MEKK-1 was further examined in a
reciprocal experiment in which anti-MEKK-1 immunoprecipitates from
nuclear extracts of control and irradiated cells were analyzed by
immunoblotting with anti-c-Abl. The results confirmed the association
of nuclear c-Abl and MEKK-1 (Fig. 3B). To determine whether MEKK-1
translocates in response to genotoxic stress, anti-MEKK-1
immunoprecipitates from nuclear lysates of control and irradiated cells
were analyzed by immunoblotting with anti-MEKK-1. The results
demonstrate little, if any, change in nuclear MEKK-1 levels in
the response to IR (data not shown). Taken together, these findings
suggest that nuclear c-Abl associates with MEKK-1 in response to
genotoxic stress.

View larger version (25K):
[in this window]
[in a new window]
|
FIG. 3.
Association of c-Abl and MEKK-1 in nuclei and cytoplasm.
U-937 cells were exposed to IR and harvested at 15 min. (A) Nuclear
lysates were subjected to immunoprecipitation with anti-c-Abl, and the
precipitates were analyzed by immunoblotting with anti-MEKK-1. (B)
Nuclear lysates from control and irradiated cells were subjected to
immunoprecipitation with anti-MEKK-1. The immunoprecipitates were
analyzed by immunoblotting with anti-c-Abl. (C) Cytoplasmic lysates
from control and irradiated cells were subjected to immunoprecipitation
with anti-MEKK-1, and the protein precipitates were analyzed by
immunoblotting with anti-c-Abl.
|
|
To determine the nature of the interaction of c-Abl and MEKK-1, lysates
from irradiated U-937 cells were incubated with GST or GST-MEKK-1, and
the resulting precipitates were analyzed by immunoblotting with
anti-c-Abl. In contrast to GST, c-Abl was detectable in the adsorbates
to GST-MEKK-1 (Fig. 4A). Since MEKK-1 has a potential binding sequence for the c-Abl SH3 domain (PCSSAPSVP; aa 967 to 975) (16, 52), lysates from irradiated U-937 cells were incubated with GST or GST-Abl SH3 (52), and the
resulting precipitates were analyzed by immunoblotting with
anti-MEKK-1. The results demonstrate that, in contrast to GST, MEKK-1
was detectable in the adsorbates to GST-c-Abl SH3 (Fig. 4B). Of note,
preparation of GST-MEKK-1 in bacteria may not accurately reflect the
interaction of endogenous MEKK-1, which is subject to different
posttranslational modifications in mammalian cells. To further assess
the interaction of c-Abl and MEKK-1, we incubated purified recombinant
c-Abl with in vitro-translated 35S-labeled His-tagged
MEKK-1. Analysis of the anti-c-Abl immunoprecipitates by
autoradiography demonstrated binding of c-Abl to MEKK-1 (Fig. 4C).
While these findings suggest that c-Abl directly associates with
MEKK-1, the results do not rule out the possibility of that protein
from the reticulocyte lysates that mediates the interaction between
c-Abl and MEKK-1.

View larger version (31K):
[in this window]
[in a new window]
|
FIG. 4.
Direct interaction of c-Abl and MEKK-1. (A) Lysates from
irradiated U-937 cells were incubated with GST or GST-MEKK-1 fusion
protein. Protein precipitates were analyzed by immunoblotting with
anti-c-Abl. (B) Lysates from irradiated U-937 cells were incubated with
GST or GST-c-Abl SH3 domain. Protein precipitates were analyzed by
immunoblotting with anti-MEKK-1. (C) The 80-kDa form of MEKK-1 was
labeled with [35S]methionine using an in vitro
translation kit. 35S-labeled MEKK-1 was incubated with
glutathione-Sepharose beads bound to GST-c-Abl (lane 1) or GST (lane
2) for 30 min at 30°C. GST-c-Abl was also incubated with buffer in
the absence of MEKK-1 (lane 3). 35S-labeled MEKK-1 was used
as a positive control (lane 4). The adsorbates were assessed by
SDS-PAGE and autoradiography.
|
|
c-Abl phosphorylates MEKK-1.
To assess in part the functional
significance of the interaction of c-Abl and MEKK-1, we incubated
purified recombinant c-Abl with eluted and heat-inactivated GST-MEKK-1
(containing the carboxy-terminal portion of the 80- to 85-kDa MEKK-1)
or GST in the presence of [
-32P]ATP. Analysis of the
reaction products demonstrated phosphorylation of GST-MEKK-1 (Fig.
5A). Similar results were obtained when a purified His-tagged MEKK-1 (aa 565 to 1100) protein was used as a
substrate for the active c-Abl kinase (data not shown). To confirm tyrosine phosphorylation of His-tagged MEKK-1, purified c-Abl was
incubated with His-tagged MEKK-1 in the presence of cold ATP. The
phosphorylated proteins were separated by SDS-PAGE, transferred to
nitrocellulose, and analyzed by immunoblotting with anti-P-Tyr. The
results demonstrate tyrosine phosphorylation of His-tagged MEKK-1 by
c-Abl (Fig. 5B). To assess c-Abl-dependent tyrosine phosphorylation of
MEKK-1 in cells, 293T cells were cotransfected with HA-MEKK-1 and
wild-type c-Abl or c-Abl(K-R). The lysates were subjected to
immunoprecipitation with anti-HA and analyzed by immunoblotting with
anti-P-Tyr antibody. To monitor expression of HA-MEKK-1, anti-HA
immunoprecipitates were also analyzed by immunoblotting with anti-HA.
The results demonstrate c-Abl kinase-dependent tyrosine phosphorylation
of MEKK-1 (Fig. 5C). To assess c-Abl-dependent tyrosine phosphorylation
of MEKK-1 in response to genotoxic stress, embryo fibroblasts from
wild-type and Abl
/
mice were treated with CDDP, and
anti-MEKK-1 immunoprecipitates were analyzed by immunoblotting with
anti-P-Tyr. The results demonstrate that treatment of wild-type, but
not Abl
/
, fibroblasts with CDDP is associated with an
increase in tyrosine phosphorylation of MEKK-1 (Fig. 5D). Taken
together, these findings support c-Abl-mediated phosphorylation of
MEKK-1 in vitro and in the response to genotoxic stress.

View larger version (41K):
[in this window]
[in a new window]
|
FIG. 5.
Phosphorylation of MEKK-1 by c-Abl. (A) Purified
recombinant c-Abl was incubated with GST (lane 2) or kinase-inactive
(heat-inactivated) GST-MEKK-1 (E. coli derived; 80-kDa
catalytic fragment) (lane 3) in the presence of
[ -32P]ATP. Heat-inactivated GST-MEKK-1 was incubated
with buffer (lane 4). As a control, purified c-Abl was incubated with
GST-Crk in the presence of [ -32P]ATP. The reaction
products were analyzed by SDS-PAGE and autoradiography. (B) Purified
recombinant c-Abl was incubated with His-tagged MEKK-1 (aa 565 to 1100;
Santa Cruz) in the presence of cold ATP. After the kinase reactions,
phosphorylated proteins were separated by SDS-PAGE, transferred to
nitrocellulose filters, and analyzed by immunoblotting with anti-P-Tyr.
(C) 293T cells were transiently cotransfected with HA-MEKK-1 and c-Abl
(lane 1) or c-Abl(K-R) (lane 2). Total cell lysates were subjected to
immunoprecipitation with anti-HA, and the precipitates were analyzed by
immunoblotting with anti-P-Tyr. (D) Embryo fibroblasts from wild-type
(MEF) or Abl / mice were treated with 50 µM CDDP for
1 h. Lysates were subjected to immunoprecipitation with
anti-MEKK-1, and the immunoprecipitates were analyzed by immunoblotting
with anti-P-Tyr (upper panel). As a control, anti-MEKK-1
immunoprecipitates were also analyzed by immunoblotting with
anti-MEKK-1 (lower panel).
|
|
c-Abl activates MEKK-1 in vitro and in the response to DNA
damage.
To determine whether c-Abl affects MEKK-1 activity,
kinase-active (yeast-derived) yMEKK-1 bound to glutathione beads was
incubated with alkaline phosphatase to inhibit constitutive
autophosphorylation. After incubation, the beads were thoroughly washed
and incubated in the presence of purified c-Abl or c-Abl(K-R) and ATP.
The GST-MEKK-1-containing beads were washed again after the first
kinase reaction and then incubated with purified SEK1(K-R) and
[
-32P]ATP. The phosphorylated products were analyzed
by SDS-PAGE and autoradiography. The results demonstrate that, in
contrast to c-Abl(K-R), preincubation of c-Abl with GST-MEKK-1 and
then removal of c-Abl is associated with induction of MEKK-1 activity
(Fig. 6A). The results also demonstrate
that phosphorylation of GST-MEKK-1 is increased in the presence of
c-Abl (Fig. 6A). As a control, protein analysis demonstrated equal
amounts of SEK1(K-R) in the kinase reactions (Fig. 6A, middle panel).
To determine if c-Abl activates MEKK-1 in cells, we transiently
overexpressed wild-type c-Abl or c-Abl(K-R) (58) in 293T
cells and measured phosphorylation of purified GST-SEK1(K-R) by
anti-MEKK-1 immunoprecipitates. The results demonstrate increased
phosphorylation of GST-SEK1(K-R) by endogenous MEKK-1 in cells
overexpressing wild-type c-Abl, but not c-Abl(K-R) (Fig. 6B). U-937
cells were also exposed to IR and anti-c-Abl immunoprecipitates were
incubated with GST-SEK1(K-R) in kinase reactions. The results
demonstrate that anti-c-Abl immunoprecipitates from IR-treated, but not
untreated, U-937 cells exhibit increased phosphorylation of
GST-SEK1(K-R) (Fig. 7A). By contrast,
incubation of purified c-Abl with GST-SEK1(K-R) demonstrated no
detectable phosphorylation (Fig. 7B). To assess c-Abl-dependent
activation of MEKK-1 in response to DNA damage, wild-type and
c-Abl
/
mouse embryo fibroblasts were treated with CDDP,
and anti-MEKK-1 immunoprecipitates were assayed by in vitro immune
complex kinase assays by using GST-SEK1(K-R) as the substrate. The
results demonstrate that treatment of wild-type, but not
c-Abl
/
, fibroblasts with CDDP is associated with an
increase in activation of MEKK-1 (Fig. 7C). These findings demonstrate
that phosphorylation of MEKK-1 by c-Abl is associated with induction of
MEKK-1 kinase activity in vitro and in response to genotoxic stress.

View larger version (40K):
[in this window]
[in a new window]
|
FIG. 6.
Activation of MEKK-1 by c-Abl. (A) Kinase-active
GST-MEKK-1 (yeast derived; yMEKK-1) bound to glutathione beads was
incubated with alkaline phosphatase. After being washed, the beads
(lanes 2 to 4) were incubated in the presence (lanes 3 and 4) or
absence (lanes 1 and 2) of purified recombinant c-Abl (lane 3) or
c-Abl(K-R) (lane 4) and ATP. The GST-MEKK-1-containing beads were
washed again and then incubated with SEK1(K-R) and
[ -32P]ATP (lanes 1 to 4). The reaction products were
analyzed by SDS-PAGE and autoradiography (upper panel). Amounts of
GST-SEK1(K-R) protein in the kinase reactions were assessed by
Coomassie blue staining (middle panel). The fold increase in
GST-SEK1(K-R) phosphorylation is expressed as the mean ± the
standard deviation of three independent experiments (bottom panel). (B)
293T cells were transiently transfected with c-Abl or c-Abl(K-R). After
48 h, lysates were subjected to immunoprecipitation with
anti-MEKK-1 (antibody 12851). The immunoprecipitates were analyzed by
in vitro immune complex kinase assays with GST-SEK1(K-R) as the
substrate (upper panel) and by immunoblotting with anti-MEKK-1 (lower
panel). Two independent transfections are shown (lanes 1 and 3 and
lanes 2 and 4).
|
|

View larger version (29K):
[in this window]
[in a new window]
|
FIG. 7.
Activation of MEKK-1 by c-Abl in vivo. (A) U-937 cells
were treated with IR and harvested after 15 min. Lysates were subjected
to immunoprecipitation with anti-c-Abl. In vitro immune complex kinase
assays were performed on the immunoprecipitates with GST-SEK1(K-R) as
the substrate. The reaction products were analyzed by SDS-PAGE and
autoradiography. (B) Purified GST-SEK1(K-R) was incubated with
[ -32P]ATP in the presence or absence of recombinant
c-Abl. Lane 1, purified c-Abl plus GST-SEK1(K-R); lane 2, c-Abl(K-R) protein plus GST-SEK1(K-R); lane 3, purified c-Abl plus
GST-Crk(120-225). The reaction products were analyzed by SDS-PAGE and
autoradiography. (C) Embryo fibroblasts from wild-type (MEF) or
c-Abl / mice were treated with 50 µM CDDP for 1 h. Lysates were subjected to immunoprecipitation with anti-MEKK-1. The
immunoprecipitates were assayed for phosphorylation of GST-SEK1(K-R).
|
|
Induction of SAPK activity by c-Abl-mediated activation of
MEKK-1.
Coupled kinase assays were performed to assess
activation of MEKK-1 in the response to DNA damage. Lysates
from control and IR-treated U-937 cells were subjected to
immunoprecipitation with anti-c-Abl. After being washed, the
immunoprecipitated proteins were incubated with purified GST-SEK1 in
the presence of Mg2+ and ATP. The ability of activated
GST-SEK1 to stimulate recombinant SAPK was determined by
SAPK-catalyzed phosphorylation of GST-Jun(2-102). Anti-c-Abl
immunoprecipitates from IR-treated, compared to untreated, cells
exhibited increased phosphorylation of GST-Jun (Fig.
8A). GST-Jun phosphorylation was not
induced if the anti-c-Abl immunoprecipitates containing MEKK-1
were incubated with purified, kinase-inactive SEK1(K-R), instead
of SEK1, in the coupled kinase assays (Fig. 8B). Moreover, there was
little if any GST-Jun phosphorylation when SEK1 or SAPK was not
included in the assays (Fig. 8B). Taken together, these results support
a model in which c-Abl activates SAPK by a MEKK-1-dependent mechanism.
However, the present studies do not exclude the possibility that c-Abl
stimulates the SAPK pathway by MEKK-1-independent mechanisms.

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 8.
IR-induced activation of MEKK-1. (A) U-937 cells were
treated with IR and harvested at 15 min. Lysates were
immunoprecipitated with anti-c-Abl (lanes 1 and 2) or rabbit anti-mouse
(lanes 3 and 4) antibodies. The immunoprecipitates were analyzed for
MEKK-1 activity in coupled-kinase assays. The bottom panel depicts the
fold activation expressed as the mean ± the standard deviation of
five independent experiments. (B) Lysates from IR-treated U-937 cells
were immunoprecipitated with anti-c-Abl (lanes 1 to 5) or preimmune
rabbit serum (not shown). The immunoprecipitates were analyzed for
MEKK-1 activity by coupled-kinase assays. Lane 1, GST-SEK1 plus
GST-SAPK plus GST-Jun; lane 2, GST-SEK1(K-R) plus GST-SAPK plus
GST-Jun; lane 3, GST-SEK1 plus GST-Jun; lane 4, GST-SAPK plus GST-Jun;
lane 5, GST-Jun. The fold activation is expressed as the mean ± the standard error (normalized to respective coupled-kinase assays
performed with PIRS immunoprecipitates) of four independent experiments
(bottom panel).
|
|
To determine whether other DNA-damaging agents activate SAPK by a
c-Abl-mediated activation of MEKK-1, U-937 cells were treated with
CDDP, and GST-Jun phosphorylation was assessed in anti-c-Abl immunoprecipitates by coupled-kinase assays. The results demonstrate that treatment of U-937 cells with CDDP is associated with a
c-Abl-mediated increase in GST-Jun phosphorylation (Fig.
9A). The results also demonstrate that
CDDP is a potent inducer of SAPK activity (Fig. 9B). In contrast to
DNA-damaging agents, TNF induces SAPK activity by a c-Abl-independent
mechanism (30, 48). In concert with these findings,
anti-c-Abl immunoprecipitates from the TNF-treated cells failed to
exhibit activation of recombinant SAPK in the coupled-kinase assays
(Fig. 8A), although TNF exposure of cells was associated with
activation of SAPK (Fig. 9C). These findings indicate that induction of
SAPK by genotoxic stress is mediated at least in part by
c-Abl-dependent activation of MEKK-1.

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 9.
CDDP-induced activation of MEKK-1. (A) U-937 cells were
treated with 50 µM CDDP for 1 h or 20 ng of TNF per ml for 10 min. Lysates were subjected to immunoprecipitation with anti-c-Abl. The
immunoprecipitates were analyzed by coupled-kinase assays. (B) U-937
cells were treated with 50 µM CDDP and harvested after 2 and 4 h. Lysates were subjected to immunoprecipitation with anti-SAPK and
assayed for phosphorylation of GST-Jun(1-102). (C) Lysates from control
and TNF-treated cells were immunoprecipitated with anti-SAPK, and in
vitro immune complex kinase assays were performed using GST-Jun as
substrate.
|
|
To further address the role of c-Abl in activation of SAPK, we
transiently transfected 293T cells with wild-type c-Abl or c-Abl(K-R)
in the presence of pEBG-SEK1 and pEBG-SAPK. The results demonstrate
that transfection of c-Abl and not c-Abl(K-R) activates SAPK (Fig.
10A). To address the relationship
between c-Abl and MEKK-1, we transiently transfected 293T cells with
c-Abl in the presence or absence of MEKK-1 or MEKK-1(K-R)
(76). The cells were also cotransfected with pEBG-SEK1 and
pEBG-SAPK. Glutathione-agarose protein complexes were assayed for in
vitro phosphorylation of GST-Jun. The results demonstrate that
transfection of MEKK-1, but not MEKK-1 (K-R), stimulates SAPK activity
and that cotransfection of c-Abl and MEKK-1 further induces SAPK
activity (Fig. 10B). The results further demonstrate that expression of
MEKK-1(K-R) blocks c-Abl-induced activation of SAPK (Fig. 10B). As a
control, immunoblot analysis of total lysates with anti-GST
demonstrated equal expression of SEK-1 and SAPK in the different
experimental conditions (data not shown).

View larger version (42K):
[in this window]
[in a new window]
|
FIG. 10.
c-Abl is an upstream activator of MEKK-1. (A) 293T
cells were cotransfected with SEK1, pEBG-SAPK, c-Abl, or c-Abl(K-R).
After 48 h, glutathione-Sepharose protein precipitates were
analyzed for GST-Jun(2-102) phosphorylation. (B) 293T cells were
transiently transfected with SEK1 (lanes 1 to 4) and pEBG-SAPK (lanes 1 to 4) and equal amounts of the following: lane 1, c-Abl plus MEKK-1;
lane 2, c-Abl plus MEKK-1(K-R); lane 3, MEKK-1; and lane 4, MEKK-1(K-R). After 48 h, glutathione-Sepharose protein
precipitates were analyzed for GST-Jun(2-102) phosphorylation. Protein
precipitates were also immunoblotted with anti-SAPK (middle panel). The
fold activation (mean ± the standard error of five independent
experiments) is shown in the bottom panel.
|
|
Previous studies have shown that dominant-negative mutants of the small
GTPases Cdc42Hs and Rac1 block SAPK activation induced by inflammatory
cytokines and tyrosine kinases (8, 66). In this context, TNF
activates SAPK by a pathway involving the Pyk2 tyrosine kinase,
Cdc42Hs, and Rac1 (8, 66). Importantly, overexpression of
the Cdc42Hs or Rac1 dominant-negative mutants failed to block
c-Abl-induced activation of SAPK (data not shown). Cdc42Hs and Rac1
function upstream to the protein kinase PAK1 (81) and MEKK-1
(8). Both PAK1 and MEKK-1 bind to Cdc42Hs and Rac1 (G. Fanger and G. Johnson, unpublished data). In concert with our results
indicating the lack of involvement of Cdc42Hs and Rac1, the
dominant-negative mutant of PAK1 failed to block activation of SAPK by
c-Abl (data not shown). These findings provide support for a model in
which MEKK-1 interacts with c-Abl in the response to DNA damage and
with the Cdc42Hs-Rac1-PAK1 complex in the activation of SAPK by
inflammatory cytokines.
 |
DISCUSSION |
DNA damage activates SAPK and c-jun gene expression.
Eukaryotic cells respond to DNA damage with cell cycle arrest,
activation of DNA repair and, under certain circumstances, induction of
apoptosis. The signals that determine cell fate, i.e., repair of DNA
damage and survival or activation of cell death mechanisms, remain
unclear. The exposure of diverse types of mammalian cells to IR and
other DNA-damaging agents is associated with induction of SAPK activity
(6, 7, 29-31, 69, 80). The findings that SAPK is also
activated in cells treated with inflammatory cytokines, heat shock,
anisomycin, and UV (9, 10, 35) have implicated the SAPK
pathway in the response to a variety of cell stresses. However, the
demonstration that SAPK is activated by mitogens (15, 46)
and that certain SAPK isoforms are required for transformation and
differentiation (24) have supported diverse functions for
this kinase. The SAPK cascade induces the phosphorylation and
activation of transcription factors that include c-Jun, Elk-1, and
ATF-2 (45). The transactivation function of c-Jun is
stimulated by SAPK-mediated phosphorylation of Ser-63 and Ser-73 sites
(10, 12, 35). Binding of activated c-Jun to the AP-1 site in
the c-jun gene promoter contributes to the activation of c-jun
transcription (1, 25). In this context, induction of SAPK
activity in the response to IR and other DNA-damaging agents is
associated with activation of c-Jun and transcription of the c-jun gene
(32, 54, 61). The functional significance of c-Jun
activation and c-jun transcription to the DNA damage response is
presumably related to the induction of later-response genes that
determine cell fate. Activation of SAPK has been linked to the
induction of apoptosis in the response to IR, TNF, and growth factor
withdrawal (69, 73). Thus, DNA-damage-induced activation of
SAPK appears to represent a signal that contributes at least in part to
the apoptotic response.
Activation of c-Abl induces SAPK activity.
The mechanisms by
which DNA damage is converted into intracellular signals that control
cell behavior are largely unknown. Genetic studies have established
that the DNA-PK complex is involved in the sensing of DNA double-strand
breaks and in the repair of these lesions. The protein kinase catalytic
subunit of DNA-PK (DNA-PKcs) is targeted to DNA breaks by
association with the Ku DNA-binding heterodimer (Ku70-Ku80)
(28). The DNA-PKcs interacts constitutively with
c-Abl (28). Importantly, DNA-PKcs/Ku complexes phosphorylate and activate c-Abl in the presence of DNA
(28). Other studies have supported a role for ATM like that
found for DNA-PK, in which signals activated by DNA lesions are
transduced to the c-Abl kinase as an effector of the DNA damage
response (2, 60). The demonstration that
Abl
/
cells exhibit a defective SAPK response to
DNA-damaging agents has supported a role for c-Abl as an upstream
effector of SAPK activation (30). Further support for
involvement of c-Abl in SAPK signaling is provided by the finding that
the introduction of c-Abl into Abl
/
cells restores
DNA-damage-induced SAPK activation (30). By contrast,
another study has reported that Abl
/
cells respond to
IR with induction of SAPK (40). The apparent discrepancy in
findings can be explained by the demonstration that activation of SAPK
by IR and other DNA-damaging agents is c-Abl dependent in proliferating
cells (30). However, confluent, growth-arrested cells fail
to exhibit c-Abl-dependent activation of SAPK in the DNA damage
response. These findings suggest that the SAPK response to IR and
certain other genotoxic agents is regulated by c-Abl-dependent and
-independent mechanisms that are dictated by the cell cycle or
cell-cell interactions. In this context, recent studies have
demonstrated that cell-cell and cell-matrix contacts play a critical
role in the regulation of SAPK and p38 MAP kinases (36).
Additional evidence in support of a role for c-Abl in the regulation of
SAPK signaling has been derived from expression of constitutively
activated forms of Abl. Overexpression of the kinase-active pGNG Abl
deleted at the SH3 domain is associated with a pronounced induction of
SAPK activity (29, 57). Other constitutively active forms,
such as Bcr-Abl and v-Abl, have also been found to induce SAPK activity
(50, 53). The present results demonstrate that the
association of c-Abl with MEKK-1 is predominantly detectable in a
nuclear complex. By contrast, activation of SAPK by oncogenic Abl
variants is mediated primarily by cytoplasmic signals and
MEKK-1-independent mechanisms. Taken together, these findings support a
model in which c-Abl activation is an upstream effector of both nuclear
and cytoplasmic SAPK signaling.
Interactions of c-Abl and MEKK-1.
Previous studies have
demonstrated that the kinase domain of MEKK-1 interacts directly with
Ras in a GTP-dependent manner (55). MEKK-1 also interacts
with Rac and Cdc42 in the induction of SAPK by epidermal growth factor
stimulation (15). In the response of cells to TNF, the
germinal center kinase (GCK) interacts with MEKK-1 in coupling of the
TNF receptor-associated factor 2 to SAPK activation (79).
Also, in phorbol ester-induced monocytic differentiation, PKC
interacts directly with MEKK-1 (24). In addition and in
concert with functioning as an upstream effector of SAPK, the
N-terminal, noncatalytic domain of MEKK-1 binds directly to SAPK
isoforms (74). The present studies demonstrate that, while
there is little, if any, constitutive association of c-Abl and MEKK-1
in cells, exposure to DNA-damaging agents induces the interaction.
Overexpression of c-Abl and MEKK-1 by transient transfection also
results in the formation of c-Abl-MEKK-1 complexes. Subcellular fractionation studies of IR-treated cells demonstrate that the interaction between c-Abl and MEKK-1 occurs predominantly in the nucleus. In addition, the finding that c-Abl phosphorylates MEKK-1 demonstrates that this interaction is direct. Other work has
demonstrated that PKC
phosphorylates and activates MEKK-1 in phorbol
ester-treated cells (24). MEKK-1 is also phosphorylated by
Pyk2 in the response of cells to TNF or UV light (13, 66).
In the present study, c-Abl-mediated phosphorylation of MEKK-1 in vitro
resulted in MEKK-1 activation. Our results also support a model in
which the activation of c-Abl in the response of cells to DNA damage
results in the induction of MEKK-1 activity. This model is further
supported by the demonstration that DNA-damage-induced SAPK activity is dependent on c-Abl-mediated activation of MEKK-1.
Interaction of c-Abl and MEKK-1 in response to specific DNA
lesions.
The demonstration that c-Abl interacts with MEKK-1 in the
response to DNA damage positions c-Abl at a level of regulation comparable to that of the Ste20 kinase in S. cerevisiae. The HPK-1 and GCK serine-threonine kinases are
mammalian homologs of Ste20 that function as upstream effectors of
SAPK. HPK-1, a kinase found in hematopoietic precursors, activates SAPK
by a mechanism involving the SH3-containing MLK-3 kinase (6, 7,
33, 65). HPK-1 interacts directly with the SH3 domain of
c-Abl (33); however, it is not known if HPK-1 interacts with
MEKK-1 or is required for c-Abl-dependent induction of SAPK activity.
GCK is expressed in the germinal center B cells of lymphoid follicles
and is activated by TNF (26, 49). The regulatory domain of
GCK binds to both TRAF2 and MEKK-1 in coupling of the TNF receptor 1 to
the SAPK pathway (79). TNF has no detectable effect on c-Abl
activation, and TNF-induced SAPK activity is mediated by a
c-Abl-independent mechanism (30, 48). These findings
distinguish TNF- and DNA-damage-induced activation of SAPK by
c-Abl-independent and -dependent mechanisms, respectively. UV-induced
activation of SAPK involves induction of Pyk2 tyrosine kinase activity
(13, 66). UV light damages DNA and also activates signaling
at the cell membrane. The available evidence indicates that UV, like
TNF, induces SAPK activity by a c-Abl-independent mechanism
(30, 48). Activation of SAPK by the alkylating agent
methyl methanesulfonate (MMS) is also mediated by a c-Abl-independent
event (48, 72). In this regard, MMS activates Pyk2 and
thereby activates SAPK (47). Thus, the available evidence
indicates that UV light and MMS activate SAPK by Pyk2-dependent signals
that originate at the cell membrane. The present findings support a
distinct model in which genotoxic agents activate nuclear c-Abl and
thereby activate the MEKK-1
SAPK pathway.
 |
ACKNOWLEDGMENTS |
This work was supported by Public Health Service grants CA75216
(S.K.) and CA55241 (D.K.) awarded by the National Cancer Institute, U.S. Department of Health and Human Services.
pEBG-SAPK, pEBG-SEK1, pEBG-SEK1(K-R) cDNAs were provided by Len
Zon and Jim Woodgett. N17 Rac-1, N17 Cdc42Hs, and
dominant-negative PAK-1 were provided by Jonathan Chernoff.
MEKK-1 CF and the MEKK-1 CF(K-R) mutant were provided by Dennis
Tempelton. Full-length HA-MEKK-1 was provided by Melanie Cobb.
Wild-type c-Abl and kinase-inactive c-Abl(K-R) were provided by Charles
Sawyers and Ruibao Ren. GST-SAPK, GST-SEK1(K-R), and GST-SEK1 were
provided by Jim Woodgett.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Dana Farber
Cancer Institute, Harvard Medical School, 44 Binney St., Boston, MA
02115. Phone: (617) 632-2938. Fax: (617) 632-2934. E-mail:
surender_kharbanda{at}dfci.harvard.edu.
 |
REFERENCES |
| 1.
|
Angel, P.,
K. Hattori,
T. Smeal, and M. Karin.
1988.
The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1.
Cell
55:875-885[CrossRef][Medline].
|
| 2.
|
Baskaran, R.,
L. D. Wood,
L. L. Whitaker,
Y. Xu,
C. Barlow,
C. E. Canman,
S. E. Morgan,
D. Baltimore,
A. Wynshaw-Boris,
M. B. Kastan, and J. Y. J. Wang.
1997.
Ataxia telangiectasia mutant protein activates c-abl tyrosine kinase in response to ionizing radiation.
Nature
387:516-519[CrossRef][Medline].
|
| 3.
|
Ben-Neriah, Y.,
A. Bernards,
M. Paskind,
G. Q. Daley, and D. Baltimore.
1986.
Alternative 5' exons in c-abl mRNA.
Cell
44:577-586[CrossRef][Medline].
|
| 4.
|
Blank, J. L.,
P. Gerwins,
E. M. Elliott,
S. Sather, and G. Johnson.
1996.
Molecular cloning of mitogen-activated protein/ERK kinase kinases (MEKK) 2 and 3. Regulation of sequential phosphorylation pathways involving mitogen-activated protein kinase and c-Jun kinase.
J. Biol. Chem.
271:5361-5368[Abstract/Free Full Text].
|
| 5.
|
Chen, R. H.,
C. Sarnecki, and J. Blenis.
1992.
Nuclear localization and regulation of erk- and rsk-encoded protein kinases.
Mol. Cell. Biol.
12:915-927[Abstract/Free Full Text].
|
| 6.
|
Chen, Y.-R.,
C. F. Meyer, and T.-H. Tan.
1996.
Persistent activation of c-Jun N-terminal kinase 1 (JNK1) in radiation-induced apoptosis.
J. Biol. Chem.
271:631-634[Abstract/Free Full Text].
|
| 7.
|
Chen, Y.-R.,
X. Wang,
D. Templeton,
R. J. Davis, and T.-H. Tan.
1996.
The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and radiation.
J. Biol. Chem.
271:31929-31936[Abstract/Free Full Text].
|
| 8.
|
Coso, O. A.,
M. Chiariello,
J. Yu,
H. Teramoto,
P. Crespo,
N. Xu,
T. Miki, and J. S. Gutkind.
1995.
The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signaling pathway.
Cell
81:1137-1146[CrossRef][Medline].
|
| 9.
|
Davis, R. J.
1994.
MAPKs: new JNK expands the group.
Trends Biochem. Sci.
19:470-473[CrossRef][Medline].
|
| 10.
|
Derijard, B.,
M. Hibi,
I. H. Wu,
T. Barrett,
B. Su,
T. Deng,
M. Karin, and R. J. Davis.
1994.
JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain.
Cell
76:1025-1037[CrossRef][Medline].
|
| 11.
|
Derijard, B.,
J. Raingeaud,
T. Barrett,
I.-H. Wu,
J. Han,
R. J. Ulevitch, and R. J. Davis.
1995.
Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms.
Science
267:682-685[Abstract/Free Full Text].
|
| 12.
|
Devary, Y.,
R. A. Gottlieb,
T. Smeal, and M. Karin.
1992.
The mammalian ultraviolet response is triggered by activation of Src tyrosine kinases.
Cell
71:1081-1091[CrossRef][Medline].
|
| 13.
|
Dikic, I.,
G. Tokiwa,
S. Lev,
S. A. Courtneidge, and J. Schlessinger.
1996.
A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation.
Nature
383:547-550[CrossRef][Medline].
|
| 14.
|
Errede, B., and D. E. Levin.
1993.
A conserved kinase cascade for MAP kinase activation in yeast.
Curr. Opin. Cell Biol.
5:254-260[CrossRef][Medline].
|
| 15.
|
Fanger, G. R.,
N. L. Johnson, and G. L. Johnson.
1997.
MEK kinases are regulated by EGF and selectively interact with Rac/Cdc42.
EMBO J.
16:4961-4972[CrossRef][Medline].
|
| 16.
|
Feller, S.,
R. Ren,
H. Hanafusa, and D. Baltimore.
1994.
SH2 and SH3 domains as molecular adhesives: the interactions of Crk and Abl.
Trends Biochem. Sci.
19:453-458[CrossRef][Medline].
|
| 17.
|
Georgiev, O.,
J. P. Bourquin,
M. Gstaiger,
L. Knoepfel,
W. Schaffner, and C. Hovens.
1996.
Two versatile eukaryotic vectors permitting epitope tagging, radiolabelling and nuclear localisation of expressed proteins.
Gene
168:165-167[CrossRef][Medline].
|
| 18.
|
Goga, A.,
X. Liu,
T. M. Hambuch,
K. Senechal,
E. Major,
A. J. Berk,
O. N. Witte, and C. L. Sawyers.
1995.
p53 dependent growth suppression by the c-Abl nuclear tyrosine kinase.
Oncogene
11:791-799[Medline].
|
| 19.
|
Herskowitz, I.
1995.
MAP kinase pathways in yeast: for mating and more.
Cell
80:187-197[CrossRef][Medline].
|
| 20.
|
Hirai, S.,
M. Izawa,
S. Osada,
G. Spyrou, and S. Ohno.
1996.
Activation of the JNK pathway by distantly related protein kinases, MEKK and MLK.
Oncogene
12:641-650[Medline].
|
| 21.
|
Hirano, M.,
S.-I. Osada,
T. Aoki,
S.-I. Hirai,
M. Hosaka,
J.-I. Inoue, and S. Ohno.
1996.
MEK kinase is involved in tumor necrosis factor -induced NF- B activation and degradation of IkB .
J. Biol. Chem.
271:13234-13238[Abstract/Free Full Text].
|
| 22.
|
Ichijo, H.,
E. Nishida,
K. Irie,
P. ten Dijke,
T. Moriguchi,
M. Takagi,
K. Matsumoto,
K. Miyazono, and Y. Gotoh.
1997.
Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways.
Science
275:90-94[Abstract/Free Full Text].
|
| 23.
|
Johnson, N. L.,
A. M. Gardner,
K. M. Diener,
C. A. Lange-Carter,
J. Gleavy,
M. B. Jarpe,
A. Minden,
M. Karin,
L. I. Zon, and G. L. Johnson.
1996.
Signal transduction pathways regulated by mitogen-activated/extracurricular response kinase kinase kinase induce cell death.
J. Biol. Chem.
271:3229-3237[Abstract/Free Full Text].
|
| 24.
|
Kaneki, M.,
S. Kharbanda,
P. Pandey,
J.-R. Liou,
R. Stone, and D. Kufe.
1999.
Functional role for protein kinase C as a regulator of stress-activated protein kinase activation and monocytic differentiation of myeloid leukemia cells.
Mol. Cell. Biol.
19:461-470[Abstract/Free Full Text].
|
| 25.
|
Karin, M.
1995.
The regulation of AP-1 activity by mitogen-activated protein kinases.
J. Biol. Chem.
270:16483-16486[Free Full Text].
|
| 26.
|
Katz, P.,
G. Whalen, and J. H. Kehrl.
1994.
Differential expression of a novel protein kinase in human B lymphocytes. Preferential localization in the germinal center.
J. Biol. Chem.
269:16802-16809[Abstract/Free Full Text].
|
| 27.
|
Kharbanda, S.,
A. Bharti,
D. Pei,
J. Wang,
P. Pandey,
R. Ren,
R. Weichselbaum,
C. T. Walsh, and D. Kufe.
1996.
The stress response to ionizing radiation involves c-Abl-dependent phosphorylation of SHPTP1.
Proc. Natl. Acad. Sci. USA
93:6898-6901[Abstract/Free Full Text].
|
| 28.
|
Kharbanda, S.,
P. Pandey,
S. Jin,
S. Inoue,
A. Bharti,
Z.-M. Yuan,
R. Weichselbaum,
D. Weaver, and D. Kufe.
1997.
Functional interaction of DNA-PK and c-Abl in response to DNA damage.
Nature
386:732-735[CrossRef][Medline].
|
| 29.
|
Kharbanda, S.,
P. Pandey,
R. Ren,
S. Feller,
B. Mayer,
L. Zon, and D. Kufe.
1995.
c-Abl activation regulates induction of the SEK1/stress activated protein kinase pathway in the cellular response to 1- -D-arabinofuranosylcytosine.
J. Biol. Chem.
270:30278-30281[Abstract/Free Full Text].
|
| 30.
|
Kharbanda, S.,
R. Ren,
P. Pandey,
T. D. Shafman,
S. M. Feller,
R. R. Weichselbaum, and D. W. Kufe.
1995.
Activation of the c-Abl tyrosine kinase in the stress response to DNA-damaging agents.
Nature
376:785-788[CrossRef][Medline].
|
| 31.
|
Kharbanda, S.,
A. Saleem,
T. Shafman,
Y. Emoto,
R. Weichselbaum,
J. Woodgett,
J. Avruch,
J. Kyriakis, and D. Kufe.
1995.
Ionizing radiation stimulates a Grb2-mediated association of the stress activated protein kinase with phosphatidylinositol 3-kinase.
J. Biol. Chem.
270:18871-18874[Abstract/Free Full Text].
|
| 32.
|
Kharbanda, S.,
M. L. Sherman, and D. W. Kufe.
1990.
Transcriptional regulation of c-jun gene expression by arabinofuranosylcytosine in human myeloid leukemia cells.
J. Clin. Investig.
86:1517-1523.
|
| 33.
|
Kiefer, F.,
L. A. Tibbles,
M. Anafi,
A. Janssen,
B. W. Zanke,
N. Lassam,
T. Pawson,
J. R. Woodgett, and N. N. Iscove.
1996.
HPK1, a hematopoietic protein kinase activating the SAPK/JNK pathway.
EMBO J.
15:7013-7025[Medline].
|
| 34.
|
Kyriakis, J. M., and J. Avruch.
1996.
Sounding the alarm: protein kinase cascades activated by stress and inflammation.
J. Biol. Chem.
271:24313-24316[Free Full Text].
|
| 35.
|
Kyriakis, J. M.,
P. Banerjee,
E. Nikolakaki,
T. Dai,
E. A. Rubie,
M. F. Ahmad,
J. Avruch, and J. R. Woodgett.
1994.
The stress-activated protein kinase subfamily of c-Jun kinases.
Nature
369:156-160[CrossRef][Medline].
|
| 36.
|
Lallemand, D.,
J. Ham,
S. Garbay,
L. Bakiri,
F. Traincard,
O. Jeannequin,
C. M. Pfarr, and M. Yaniv.
1998.
Stress-activated protein kinases are negatively regulated by cell density.
EMBO J.
17:5615-5626[CrossRef][Medline].
|
| 37.
|
Lange-Carter, C. A., and G. L. Johnson.
1994.
Ras-dependent growth factor regulation of MEK kinase in PC12 cells.
Science
265:1458-1461[Abstract/Free Full Text].
|
| 38.
|
Lange-Carter, C. A.,
C. M. Pleiman,
A. M. Gardner,
K. J. Blumer, and G. J. Johnson.
1994.
A divergence in the MAP kinase regulatory network defined by MEK kinase and Raf.
Science
260:315-319.
|
| 39.
|
Lin, A.,
A. Minden,
H. Martinetto,
F.-X. Claret,
C. Lange-Carter,
F. Mercurio,
G. L. Johnson, and M. Karin.
1995.
Identification of a dual specificity kinase that activates the Jun kinases and p38-Mpk2.
Science
268:286-290[Abstract/Free Full Text].
|
| 40.
|
Liu, Z.-G.,
R. Baskaran,
E. T. Lea-Chou,
L. Wood,
Y. Chen,
M. Karin, and J. Y. J. Wang.
1996.
Three distinct signalling responses by murine fibroblasts to genotoxic stress.
Nature
384:273-276[CrossRef][Medline].
|
| 41.
|
Liu, Z.-G.,
R. Baskaran,
E. T. Lea-Chou,
L. Wood,
Y. Chen,
M. Karin, and J. Y. J. Wang.
1996.
Three distinct signalling responses by murine fibroblasts to genotoxic stress.
Nature
384:273-276.
|
| 42.
|
Manser, E.,
T. Leung,
H. Salihuddin,
Z. S. Zhao, and L. Lim.
1994.
A brain serine/threonine protein kinase activated by Cdc42 and Rac1.
Nature
367:40-46[CrossRef][Medline].
|
| 43.
|
Marshall, C. J.
1995.
Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation.
Cell
80:179-185[CrossRef][Medline].
|
| 44.
|
Mattioni, T.,
P. K. Jackson,
O. Bchini-Hooft van Huijsduijnen, and D. Picard.
1995.
Cell cycle arrest by tyrosine kinase Abl involves altered early mitogenic response.
Oncogene
10:1325-1333[Medline].
|
| 45.
|
Minden, A., and M. Karin.
1997.
Regulation and function of the JNK subgroup of MAP kinases.
Biochim. Biophys. Acta
1333:F85-104[Medline].
|
| 46.
|
Minden, A.,
A. Lin,
M. McMahon,
C. Lange-Carter,
B. Derijard,
R. J. Davis,
G. L. Johnson, and M. Karin.
1994.
Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK.
Science
266:1719-1723[Abstract/Free Full Text].
|
| 47.
|
Pandey, P.,
S. Avraham,
A. Place,
V. Kumar,
P. Majumder,
K. Cheng,
A. Nakazawa,
S. Saxena, and S. Kharbanda.
1999.
Bcl-xL blocks activation of related adhesion focal tyrosine kinase/proline-rich tyrosine kinase 2 and stress-activated protein kinase/c-Jun N-terminal protein kinase in the cellular response to methylmethane sulfonate.
J. Biol. Chem.
274:8618-8623[Abstract/Free Full Text].
|
| 48.
|
Pandey, P.,
J. Raingeaud,
M. Kaneki,
R. Weichselbaum,
R. Davis,
D. Kufe, and S. Kharbanda.
1996.
Activation of p38 MAP kinase by c-Abl-dependent and -independent mechanisms.
J. Biol. Chem.
271:23775-23779[Abstract/Free Full Text].
|
| 49.
|
Pombo, C. M.,
J. H. Kehrl,
I. Sanchez,
P. Katz,
J. Avruch,
L. I. Zon,
J. R. Woodgett,
T. Force, and J. M. Kyriakis.
1995.
Activation of the SAPK pathway by the human STE20 homologue germinal centre kinase.
Nature
377:750-754[CrossRef][Medline].
|
| 50.
|
Raitano, A. B.,
J. R. Halpern,
T. M. Hambuch, and C. L. Sawyers.
1995.
The Bcr-Abl leukemia oncogene activates Jun kinase and requires Jun for transformation.
Proc. Natl. Acad. Sci. USA
92:11746-11750[Abstract/Free Full Text].
|
| 51.
|
Rana, A.,
K. Gallo,
P. Godowski,
S.-I. Hirai,
S. Ohno,
L. Zon,
J. M. Kyriakis, and J. Avruch.
1996.
The mixed lineage kinase SPRK phosphorylates and activates the stress-activated protein kinase activator, SEK-1.
J. Biol. Chem.
271:19025-19028[Abstract/Free Full Text].
|
| 52.
|
Ren, R.,
Z.-S. Ye, and D. Baltimore.
1994.
Abl protein-tyrosine kinase selects the Crk adapter as a substrate using SH3-binding sites.
Genes Dev.
8:783-795[Abstract/Free Full Text].
|
| 53.
|
Renshaw, M. W.,
E. Lea-Chou, and J. Y. J. Wang.
1996.
Rac is required for v-Abl tyrosine kinase to activate mitogenesis.
Curr. Biol.
6:76-83[CrossRef][Medline].
|
| 54.
|
Rubin, E.,
S. Kharbanda,
H. Gunji, and D. Kufe.
1991.
Activation of the c-jun protooncogene in human myeloid leukemia cells treated with etoposide.
Mol. Pharmacol.
39:697-701[Abstract].
|
| 55.
|
Russell, M.,
C. A. Lange-Carter, and G. L. Johnson.
1995.
Direct interaction between Ras and the kinase domain of mitogen-activated protein kinase kinase kinase (MEKK1).
J. Biol. Chem.
270:11757-11760[Abstract/Free Full |